Home \ Therapy \ Peculiarities of managing elderly patients in clinical practice

Features of conducting elderly patients in clinical practice

The brain in focus of arterial hypertension

Peculiarities of managing elderly patients

The brain is a key target organ for treatment of cerebrovascular risks

Mexidol as a geroprotector: potential and prospects

Neuroprotection in arterial hypertension and cognitive impairment

The Connection Between Vascular Diseases of the Brain and Eye: A Neurologist and Ophthalmologist's Perspective

Ischemic stroke: clinical guidelines and practical aspects

NIHSS and mRS: Gold Standards in Neuroscience

Cognitive impairment caused by arterial hypertension: from clinical guidelines to practical algorithms

The brain is a target organ for arterial hypertension: features of management of the elderly patient

Time codes:

03:14
The structure of medical care for elderly and senile patients. The role of the geriatricra.
05:22
The problem of conducting elderly patients
08:33
Features of pharmacotherapy of elderly and senile patients
10:50
Cognitive disorders and their relationship with age
15:00
The choice of neurocytoprotective therapy
18:10
Mexidol®: Properties and clinical research
20:50
The role of Mexidol® in eliminating mitochondrial dysfunction.
22:00
Subanaliz of the drug Mexidol® in different age groups.

Ostroumova Olga Dmitrievna – Doctor of Medical Sciences, Professor, Head. Department of Therapy and Polymorbid Pathology named after. Academician M.S. Vovsi FSBEI DPO RMANPE Ministry of Health of Russia

Anna Nikolaevna Bogolepova – Doctor of Medical Sciences, Professor of the Department of Neurology, Neurosurgery and Medical Genetics of the Faculty of Medicine of the Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation

Announcement:

The free-radical theory of aging explains the imbalance in the pro- and antioxidant systems, leading to mitochondrial dysfunction and premature aging. Experimental animal studies have shown that Mexidol®activates mitochondrial functioning and reverses mitochondrial dysfunction. This leads to results such as increased lifespan and normalized behavioral responses. Accordingly, taking Mexidol® in old age can improve the quality and duration of life.

All videos Next video

The brain in focus of arterial hypertension

Peculiarities of managing elderly patients

The brain is a key target organ for treatment of cerebrovascular risks

Mexidol as a geroprotector: potential and prospects

Neuroprotection in arterial hypertension and cognitive impairment

The Connection Between Vascular Diseases of the Brain and Eye: A Neurologist and Ophthalmologist's Perspective

Ischemic stroke: clinical guidelines and practical aspects

NIHSS and mRS: Gold Standards in Neuroscience

Cognitive impairment caused by arterial hypertension: from clinical guidelines to practical algorithms

The brain is a target organ for arterial hypertension: features of management of the elderly patient

Time codes:

03:14
The structure of medical care for elderly and senile patients. The role of the geriatricra.
05:22
The problem of conducting elderly patients
08:33
Features of pharmacotherapy of elderly and senile patients
10:50
Cognitive disorders and their relationship with age
15:00
The choice of neurocytoprotective therapy
18:10
Mexidol®: Properties and clinical research
20:50
The role of Mexidol® in eliminating mitochondrial dysfunction.
22:00
Subanaliz of the drug Mexidol® in different age groups.

Block of articles on this topic

Features of pharmacotherapy of vascular cognitive impairment in elderly people

Author:
A.N. BOGOLEPOVA^1,²

¹N.I. Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation, Moscow, Russia;
²Federal Center for Brain and Neurotechnology of the Federal Medical and Biological Agency of Russia, Moscow, Russia

Approaches to pharmacotherapy of vascular moderate cognitive disorders in patients of various age groups

Authors:
V.V. ZAKHAROV¹, A.I. FEDIN², E.A. MKHITARYAN^2,³

The effectiveness of Mexidol in patients of different age groups with chronic brain ischemia with cognitive disorders (the results of subanalysis of the international multicenter randomized double blind placebo-controlled study of memes)

Authors:
V.V. ZAKHAROV¹, O.N. TKACHEV^2,³, E.A. MKHITARYAN^2,³, A.I. FEDIN²

Cognitive disorders in the practice of a primary link: Focus for patients with arterial hypertension

Authors:
O.D. OSTROUMOVA, A.I. KOCHETKOV, N.A. SHATALOVA

Cognitive disorders of vascular genesis in the practice of the therapist

Author:
P.R. KAMCHATNOV¹, R.A. CHEREMIN², L.A. SKIPETROVA², A.V. CHUGUNOV¹

¹Federal State Autonomous Educational Institution of Higher Education “N.I. Pirogov Russian National Medical University” of the Ministry of Health of the Russian Federation, Moscow
²State Budgetary Healthcare Institution “Center for Speech Pathology and Neurorehabilitation of the Moscow Department of Health”

THE INFORMATION IS INTENDED FOR HEALTHCARE AND PHARMACEUTICAL PROFESSIONALS. THIS INFORMATION IS NOT INTENDED AS A SUBSTITUTE FOR MEDICAL ADVICE.

Source of photos and images Shutterstock.com